Completed
A Study to Evaluate the Safety and Effectiveness of ALKS 2680 in Subjects With Narcolepsy Type 2
NCT06555783
- Conditions
- Disorders of Excessive Somnolence, Dyssomnias, Mental Disorders, +8 more
- Locations
-
- Alkermes Investigator Site Little Rock, Arkansas, United States
- Alkermes Investigator Site Los Angeles, California, United States
- Alkermes Investigator Site Redwood City, California, United States
- Alkermes Investigator Site San Francisco, California, United States